世界のサイトメガロウイルス（HHV-5）感染症治療薬市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4095 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、129ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、サイトメガロウイルス（HHV-5）感染症治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口薬、注射）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・サイトメガロウイルス（HHV-5）感染症治療薬の市場動向 ・企業の競争状況、市場シェア ・サイトメガロウイルス（HHV-5）感染症治療薬の種類別市場規模と予測2016-2027（経口薬、注射） ・サイトメガロウイルス（HHV-5）感染症治療薬の用途別市場規模と予測2016-2027（病院、診療所、その他） ・サイトメガロウイルス（HHV-5）感染症治療薬の北米市場規模2016-2027（アメリカ、カナダ） ・サイトメガロウイルス（HHV-5）感染症治療薬の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・サイトメガロウイルス（HHV-5）感染症治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・サイトメガロウイルス（HHV-5）感染症治療薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・サイトメガロウイルス（HHV-5）感染症治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（3-V Biosciences, Inc.、AIMM Therapeutics、AlphaVax、Altor BioScience、Applied Immune、Astellas、BioApex、Bionor Pharma、Biotest、Pfizer、Cell Medica、Chimerix、GSK、Hookipa Biotech、Humabs BioMed、Inagen、Kadmon Corporation、Lead Discovery Center、Merck、Novartis） ・結論

A drug used to treat giant cell infections.

Market Analysis and Insights: Global Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market
The global Cytomegalovirus（HHV-5）Infection Therapeutic Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Cytomegalovirus（HHV-5）Infection Therapeutic Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Cytomegalovirus（HHV-5）Infection Therapeutic Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Cytomegalovirus（HHV-5）Infection Therapeutic Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Cytomegalovirus（HHV-5）Infection Therapeutic Drugs market.

Global Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Scope and Market Size
Cytomegalovirus（HHV-5）Infection Therapeutic Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Cytomegalovirus（HHV-5）Infection Therapeutic Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Oral Medication
Injection

Segment by Application
Hospital
Clinic
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
3-V Biosciences, Inc.
AIMM Therapeutics
AlphaVax
Altor BioScience
Applied Immune
Astellas
BioApex
Bionor Pharma
Biotest
Pfizer
Cell Medica
Chimerix
GSK
Hookipa Biotech
Humabs BioMed
Inagen
Kadmon Corporation
Lead Discovery Center
Merck
Novartis

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Oral Medication
1.2.3 Injection
1.3 Market by Application
1.3.1 Global Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Perspective (2016-2027)
2.2 Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Growth Trends by Regions
2.2.1 Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Historic Market Share by Regions (2016-2021)
2.2.3 Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Forecasted Market Size by Regions (2022-2027)
2.3 Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Industry Dynamic
2.3.1 Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Trends
2.3.2 Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Drivers
2.3.3 Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Challenges
2.3.4 Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Players by Revenue
3.1.1 Global Top Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Players by Revenue (2016-2021)
3.1.2 Global Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue Market Share by Players (2016-2021)
3.2 Global Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue
3.4 Global Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Concentration Ratio
3.4.1 Global Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue in 2020
3.5 Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Key Players Head office and Area Served
3.6 Key Players Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Product Solution and Service
3.7 Date of Enter into Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Breakdown Data by Type
4.1 Global Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Historic Market Size by Type (2016-2021)
4.2 Global Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Forecasted Market Size by Type (2022-2027)

5 Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Breakdown Data by Application
5.1 Global Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Historic Market Size by Application (2016-2021)
5.2 Global Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size (2016-2027)
6.2 North America Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size by Type
6.2.1 North America Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size by Type (2016-2021)
6.2.2 North America Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size by Type (2022-2027)
6.2.3 North America Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size by Type (2016-2027)
6.3 North America Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size by Application
6.3.1 North America Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size by Application (2016-2021)
6.3.2 North America Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size by Application (2022-2027)
6.3.3 North America Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size by Application (2016-2027)
6.4 North America Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size by Country
6.4.1 North America Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size by Country (2016-2021)
6.4.2 North America Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size (2016-2027)
7.2 Europe Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size by Type
7.2.1 Europe Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size by Type (2016-2021)
7.2.2 Europe Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size by Type (2022-2027)
7.2.3 Europe Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size by Type (2016-2027)
7.3 Europe Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size by Application
7.3.1 Europe Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size by Application (2016-2021)
7.3.2 Europe Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size by Application (2022-2027)
7.3.3 Europe Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size by Application (2016-2027)
7.4 Europe Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size by Country
7.4.1 Europe Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size by Country (2016-2021)
7.4.2 Europe Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size (2016-2027)
8.2 Asia-Pacific Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size by Type
8.2.1 Asia-Pacific Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size by Type (2016-2027)
8.3 Asia-Pacific Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size by Application
8.3.1 Asia-Pacific Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size by Application (2016-2027)
8.4 Asia-Pacific Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size by Region
8.4.1 Asia-Pacific Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size (2016-2027)
9.2 Latin America Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size by Type
9.2.1 Latin America Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size by Type (2016-2021)
9.2.2 Latin America Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size by Type (2022-2027)
9.2.3 Latin America Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size by Type (2016-2027)
9.3 Latin America Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size by Application
9.3.1 Latin America Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size by Application (2016-2021)
9.3.2 Latin America Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size by Application (2022-2027)
9.3.3 Latin America Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size by Application (2016-2027)
9.4 Latin America Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size by Country
9.4.1 Latin America Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size by Country (2016-2021)
9.4.2 Latin America Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size (2016-2027)
10.2 Middle East & Africa Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size by Type
10.2.1 Middle East & Africa Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size by Type (2016-2027)
10.3 Middle East & Africa Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size by Application
10.3.1 Middle East & Africa Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size by Application (2016-2027)
10.4 Middle East & Africa Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size by Country
10.4.1 Middle East & Africa Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 3-V Biosciences, Inc.
11.1.1 3-V Biosciences, Inc. Company Details
11.1.2 3-V Biosciences, Inc. Business Overview
11.1.3 3-V Biosciences, Inc. Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Introduction
11.1.4 3-V Biosciences, Inc. Revenue in Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Business (2016-2021)
11.1.5 3-V Biosciences, Inc. Recent Development
11.2 AIMM Therapeutics
11.2.1 AIMM Therapeutics Company Details
11.2.2 AIMM Therapeutics Business Overview
11.2.3 AIMM Therapeutics Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Introduction
11.2.4 AIMM Therapeutics Revenue in Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Business (2016-2021)
11.2.5 AIMM Therapeutics Recent Development
11.3 AlphaVax
11.3.1 AlphaVax Company Details
11.3.2 AlphaVax Business Overview
11.3.3 AlphaVax Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Introduction
11.3.4 AlphaVax Revenue in Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Business (2016-2021)
11.3.5 AlphaVax Recent Development
11.4 Altor BioScience
11.4.1 Altor BioScience Company Details
11.4.2 Altor BioScience Business Overview
11.4.3 Altor BioScience Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Introduction
11.4.4 Altor BioScience Revenue in Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Business (2016-2021)
11.4.5 Altor BioScience Recent Development
11.5 Applied Immune
11.5.1 Applied Immune Company Details
11.5.2 Applied Immune Business Overview
11.5.3 Applied Immune Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Introduction
11.5.4 Applied Immune Revenue in Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Business (2016-2021)
11.5.5 Applied Immune Recent Development
11.6 Astellas
11.6.1 Astellas Company Details
11.6.2 Astellas Business Overview
11.6.3 Astellas Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Introduction
11.6.4 Astellas Revenue in Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Business (2016-2021)
11.6.5 Astellas Recent Development
11.7 BioApex
11.7.1 BioApex Company Details
11.7.2 BioApex Business Overview
11.7.3 BioApex Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Introduction
11.7.4 BioApex Revenue in Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Business (2016-2021)
11.7.5 BioApex Recent Development
11.8 Bionor Pharma
11.8.1 Bionor Pharma Company Details
11.8.2 Bionor Pharma Business Overview
11.8.3 Bionor Pharma Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Introduction
11.8.4 Bionor Pharma Revenue in Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Business (2016-2021)
11.8.5 Bionor Pharma Recent Development
11.9 Biotest
11.9.1 Biotest Company Details
11.9.2 Biotest Business Overview
11.9.3 Biotest Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Introduction
11.9.4 Biotest Revenue in Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Business (2016-2021)
11.9.5 Biotest Recent Development
11.10 Pfizer
11.10.1 Pfizer Company Details
11.10.2 Pfizer Business Overview
11.10.3 Pfizer Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Introduction
11.10.4 Pfizer Revenue in Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Business (2016-2021)
11.10.5 Pfizer Recent Development
11.11 Cell Medica
11.11.1 Cell Medica Company Details
11.11.2 Cell Medica Business Overview
11.11.3 Cell Medica Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Introduction
11.11.4 Cell Medica Revenue in Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Business (2016-2021)
11.11.5 Cell Medica Recent Development
11.12 Chimerix
11.12.1 Chimerix Company Details
11.12.2 Chimerix Business Overview
11.12.3 Chimerix Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Introduction
11.12.4 Chimerix Revenue in Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Business (2016-2021)
11.12.5 Chimerix Recent Development
11.13 GSK
11.13.1 GSK Company Details
11.13.2 GSK Business Overview
11.13.3 GSK Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Introduction
11.13.4 GSK Revenue in Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Business (2016-2021)
11.13.5 GSK Recent Development
11.14 Hookipa Biotech
11.14.1 Hookipa Biotech Company Details
11.14.2 Hookipa Biotech Business Overview
11.14.3 Hookipa Biotech Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Introduction
11.14.4 Hookipa Biotech Revenue in Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Business (2016-2021)
11.14.5 Hookipa Biotech Recent Development
11.15 Humabs BioMed
11.15.1 Humabs BioMed Company Details
11.15.2 Humabs BioMed Business Overview
11.15.3 Humabs BioMed Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Introduction
11.15.4 Humabs BioMed Revenue in Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Business (2016-2021)
11.15.5 Humabs BioMed Recent Development
11.16 Inagen
11.16.1 Inagen Company Details
11.16.2 Inagen Business Overview
11.16.3 Inagen Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Introduction
11.16.4 Inagen Revenue in Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Business (2016-2021)
11.16.5 Inagen Recent Development
11.17 Kadmon Corporation
11.17.1 Kadmon Corporation Company Details
11.17.2 Kadmon Corporation Business Overview
11.17.3 Kadmon Corporation Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Introduction
11.17.4 Kadmon Corporation Revenue in Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Business (2016-2021)
11.17.5 Kadmon Corporation Recent Development
11.18 Lead Discovery Center
11.18.1 Lead Discovery Center Company Details
11.18.2 Lead Discovery Center Business Overview
11.18.3 Lead Discovery Center Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Introduction
11.18.4 Lead Discovery Center Revenue in Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Business (2016-2021)
11.18.5 Lead Discovery Center Recent Development
11.18 Merck
.1 Merck Company Details
.2 Merck Business Overview
.3 Merck Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Introduction
.4 Merck Revenue in Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Business (2016-2021)
.5 Merck Recent Development
11.20 Novartis
11.20.1 Novartis Company Details
11.20.2 Novartis Business Overview
11.20.3 Novartis Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Introduction
11.20.4 Novartis Revenue in Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Business (2016-2021)
11.20.5 Novartis Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Oral Medication
Table 3. Key Players of Injection
Table 4. Global Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Share by Regions (2016-2021)
Table 8. Global Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Share by Regions (2022-2027)
Table 10. Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Trends
Table 11. Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Drivers
Table 12. Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Challenges
Table 13. Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Restraints
Table 14. Global Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Share by Players (2016-2021)
Table 16. Global Top Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cytomegalovirus（HHV-5）Infection Therapeutic Drugs as of 2020)
Table 17. Ranking of Global Top Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Product Solution and Service
Table 21. Date of Enter into Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue Market Share by Type (2016-2021)
Table 25. Global Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue Market Share by Application (2016-2021)
Table 29. Global Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 61. 3-V Biosciences, Inc. Company Details
Table 62. 3-V Biosciences, Inc. Business Overview
Table 63. 3-V Biosciences, Inc. Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Product
Table 64. 3-V Biosciences, Inc. Revenue in Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Business (2016-2021) & (US$ Million)
Table 65. 3-V Biosciences, Inc. Recent Development
Table 66. AIMM Therapeutics Company Details
Table 67. AIMM Therapeutics Business Overview
Table 68. AIMM Therapeutics Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Product
Table 69. AIMM Therapeutics Revenue in Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Business (2016-2021) & (US$ Million)
Table 70. AIMM Therapeutics Recent Development
Table 71. AlphaVax Company Details
Table 72. AlphaVax Business Overview
Table 73. AlphaVax Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Product
Table 74. AlphaVax Revenue in Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Business (2016-2021) & (US$ Million)
Table 75. AlphaVax Recent Development
Table 76. Altor BioScience Company Details
Table 77. Altor BioScience Business Overview
Table 78. Altor BioScience Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Product
Table 79. Altor BioScience Revenue in Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Business (2016-2021) & (US$ Million)
Table 80. Altor BioScience Recent Development
Table 81. Applied Immune Company Details
Table 82. Applied Immune Business Overview
Table 83. Applied Immune Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Product
Table 84. Applied Immune Revenue in Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Business (2016-2021) & (US$ Million)
Table 85. Applied Immune Recent Development
Table 86. Astellas Company Details
Table 87. Astellas Business Overview
Table 88. Astellas Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Product
Table 89. Astellas Revenue in Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Business (2016-2021) & (US$ Million)
Table 90. Astellas Recent Development
Table 91. BioApex Company Details
Table 92. BioApex Business Overview
Table 93. BioApex Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Product
Table 94. BioApex Revenue in Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Business (2016-2021) & (US$ Million)
Table 95. BioApex Recent Development
Table 96. Bionor Pharma Company Details
Table 97. Bionor Pharma Business Overview
Table 98. Bionor Pharma Revenue in Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Business (2016-2021) & (US$ Million)
Table 99. Bionor Pharma Recent Development
Table 100. Biotest Company Details
Table 101. Biotest Business Overview
Table 102. Biotest Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Product
Table 103. Biotest Revenue in Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Business (2016-2021) & (US$ Million)
Table 104. Biotest Recent Development
Table 105. Pfizer Company Details
Table 106. Pfizer Business Overview
Table 107. Pfizer Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Product
Table 108. Pfizer Revenue in Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Business (2016-2021) & (US$ Million)
Table 109. Pfizer Recent Development
Table 110. Cell Medica Company Details
Table 111. Cell Medica Business Overview
Table 112. Cell Medica Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Product
Table 113. Cell Medica Revenue in Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Business (2016-2021) & (US$ Million)
Table 114. Cell Medica Recent Development
Table 115. Chimerix Company Details
Table 116. Chimerix Business Overview
Table 117. Chimerix Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Product
Table 118. Chimerix Revenue in Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Business (2016-2021) & (US$ Million)
Table 119. Chimerix Recent Development
Table 120. GSK Company Details
Table 121. GSK Business Overview
Table 122. GSK Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Product
Table 123. GSK Revenue in Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Business (2016-2021) & (US$ Million)
Table 124. GSK Recent Development
Table 125. Hookipa Biotech Company Details
Table 126. Hookipa Biotech Business Overview
Table 127. Hookipa Biotech Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Product
Table 128. Hookipa Biotech Revenue in Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Business (2016-2021) & (US$ Million)
Table 129. Hookipa Biotech Recent Development
Table 130. Humabs BioMed Company Details
Table 131. Humabs BioMed Business Overview
Table 132. Humabs BioMed Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Product
Table 133. Humabs BioMed Revenue in Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Business (2016-2021) & (US$ Million)
Table 134. Humabs BioMed Recent Development
Table 135. Inagen Company Details
Table 136. Inagen Business Overview
Table 137. Inagen Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Product
Table 138. Inagen Revenue in Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Business (2016-2021) & (US$ Million)
Table 139. Inagen Recent Development
Table 140. Kadmon Corporation Company Details
Table 141. Kadmon Corporation Business Overview
Table 142. Kadmon Corporation Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Product
Table 143. Kadmon Corporation Revenue in Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Business (2016-2021) & (US$ Million)
Table 144. Kadmon Corporation Recent Development
Table 145. Lead Discovery Center Company Details
Table 146. Lead Discovery Center Business Overview
Table 147. Lead Discovery Center Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Product
Table 148. Lead Discovery Center Revenue in Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Business (2016-2021) & (US$ Million)
Table 149. Lead Discovery Center Recent Development
Table 150. Merck Company Details
Table 151. Merck Business Overview
Table 152. Merck Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Product
Table 153. Merck Revenue in Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Business (2016-2021) & (US$ Million)
Table 154. Merck Recent Development
Table 155. Novartis Company Details
Table 156. Novartis Business Overview
Table 157. Novartis Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Product
Table 158. Novartis Revenue in Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Business (2016-2021) & (US$ Million)
Table 159. Novartis Recent Development
Table 160. Research Programs/Design for This Report
Table 161. Key Data Information from Secondary Sources
Table 162. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Share by Type: 2020 VS 2027
Figure 2. Oral Medication Features
Figure 3. Injection Features
Figure 4. Global Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Share by Application: 2020 VS 2027
Figure 5. Hospital Case Studies
Figure 6. Clinic Case Studies
Figure 7. Other Case Studies
Figure 8. Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Report Years Considered
Figure 9. Global Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Share by Regions: 2020 VS 2027
Figure 12. Global Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Share by Regions (2022-2027)
Figure 13. Global Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Share by Players in 2020
Figure 14. Global Top Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cytomegalovirus（HHV-5）Infection Therapeutic Drugs as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue in 2020
Figure 16. Global Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue Market Share by Type (2016-2021)
Figure 17. Global Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue Market Share by Type (2022-2027)
Figure 18. North America Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Share by Type (2016-2027)
Figure 20. North America Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Share by Application (2016-2027)
Figure 21. North America Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Share by Country (2016-2027)
Figure 22. United States Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Share by Type (2016-2027)
Figure 26. Europe Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Share by Application (2016-2027)
Figure 27. Europe Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Share by Country (2016-2027)
Figure 28. Germany Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Share by Region (2016-2027)
Figure 38. China Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Share by Type (2016-2027)
Figure 46. Latin America Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Share by Application (2016-2027)
Figure 47. Latin America Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Share by Country (2016-2027)
Figure 48. Mexico Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Share by Country (2016-2027)
Figure 54. Turkey Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. 3-V Biosciences, Inc. Revenue Growth Rate in Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Business (2016-2021)
Figure 58. AIMM Therapeutics Revenue Growth Rate in Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Business (2016-2021)
Figure 59. AlphaVax Revenue Growth Rate in Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Business (2016-2021)
Figure 60. Altor BioScience Revenue Growth Rate in Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Business (2016-2021)
Figure 61. Applied Immune Revenue Growth Rate in Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Business (2016-2021)
Figure 62. Astellas Revenue Growth Rate in Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Business (2016-2021)
Figure 63. BioApex Revenue Growth Rate in Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Business (2016-2021)
Figure 64. Bionor Pharma Revenue Growth Rate in Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Business (2016-2021)
Figure 65. Biotest Revenue Growth Rate in Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Business (2016-2021)
Figure 66. Pfizer Revenue Growth Rate in Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Business (2016-2021)
Figure 67. Cell Medica Revenue Growth Rate in Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Business (2016-2021)
Figure 68. Chimerix Revenue Growth Rate in Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Business (2016-2021)
Figure 69. GSK Revenue Growth Rate in Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Business (2016-2021)
Figure 70. Hookipa Biotech Revenue Growth Rate in Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Business (2016-2021)
Figure 71. Humabs BioMed Revenue Growth Rate in Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Business (2016-2021)
Figure 72. Inagen Revenue Growth Rate in Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Business (2016-2021)
Figure 73. Kadmon Corporation Revenue Growth Rate in Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Business (2016-2021)
Figure 74. Lead Discovery Center Revenue Growth Rate in Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Business (2016-2021)
Figure 75. Merck Revenue Growth Rate in Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Business (2016-2021)
Figure 76. Novartis Revenue Growth Rate in Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Business (2016-2021)
Figure 77. Bottom-up and Top-down Approaches for This Report
Figure 78. Data Triangulation
Figure 79. Key Executives Interviewed

---